Pre-earnings options volume in Ardelyx is normal with calls leading puts 7:4. Implied volatility suggests the market is anticipating a move near 11.4%, or 63c, after results are released. Median move over the past eight quarters is 4.4%.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARDX:
- Ardelyx announces publication of two plain language summaries from XPHOZAH
- Ardelyx Announces Publication of Two Plain Language Summaries from XPHOZAH® (tenapanor) Clinical Trials in Current Medical Research and Opinion
- ARDX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Ardelyx lawsuit unlikely to succeed, says H.C. Wainwright
- Ardelyx files lawsuit against CMS over tenapanor and ESRD PPS